98%
921
2 minutes
20
Objective: Juvenile recurrent parotitis (JRP) is a rare disease that may adversely affect normal development and quality of life. The objective of this study was to report on the demographics, characteristics, and treatment outcomes of JRP and to offer evidence-based management recommendations.
Study Design: Retrospective review.
Setting: A single tertiary care pediatric teaching hospital.
Methods: Medical records, imaging studies, and laboratory findings over a 10-year period were retrospectively collected and reviewed, resulting in 41 patients with JRP between the ages of 8 months and 16 years.
Results: Black males aged 2 to 8 years were most commonly affected by JRP. Overall, 18 (44%) patients received ≥3 antibiotics, and 17 (42%) underwent sialendoscopy for treatment. Over 75% of patients had no JRP recurrences after 3 sialendoscopies. The most common imaging approach was computed tomography (42%), and the most frequent laboratory results were elevated amylase (83%) and C-reactive protein (82%). Atopy (61%) and excess weight (42%) were routinely associated with JRP, especially in severe cases.
Conclusion: JRP workup and treatment plans should begin with the least burdening modalities, including over-the-counter analgesics, minimal laboratory studies in the acute phase, and ultrasonography over computed tomography. Clindamycin is an effective initial antibiotic of choice, and severe recurrences may be controlled with sialendoscopy. Optimizing the health of patients with JRP includes managing comorbidities, especially of atopic and overweight origins, which are associated with more severe cases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848064 | PMC |
http://dx.doi.org/10.1177/2473974X221077874 | DOI Listing |
Eur J Pediatr
August 2025
Department of Social Medicine, National Center for Child Health and Development, Setagaya-Ku, Tokyo, Japan.
Unlabelled: This study investigated the association between the frequency and number of major somatic symptoms (headache, stomachache, back pain, dizziness) and depressive symptoms among adolescents. We conducted a nationwide, population-based self-reported questionnaire survey of adolescents aged 10-15. We defined depressive symptoms as scoring 10 or higher on the Patient Health Questionnaire for Adolescents.
View Article and Find Full Text PDFJ Clin Med
July 2025
2nd Academic ORL, Head and Neck Surgery Department, Aristotle University of Thessaloniki, Papageorgiou Hospital, 56403 Thessaloniki, Greece.
Recent evidence has suggested that sialendoscopy should be the first-line treatment for chronic sialadenitis. This study aimed to assess the efficacy of steroid irrigation during sialendoscopy in non-lithiasic chronic sialadenitis. We conducted a systematic search of the databases of PubMed, Scopus, and Web of Science up to the 3rd of November 2024 for completed studies investigating the efficacy of steroid irrigation during sialendoscopy for chronic non-lithiasic sialadenitis.
View Article and Find Full Text PDFNat Med
August 2025
Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
Cellular immunity, mediated by tumor antigen-specific CD4 and CD8 T cells, has a critical role in the success of cancer immunotherapy by targeting intracellular driver and passenger tumor mutations. We present the final results of the phase 1 AMPLIFY-201 trial, in which patients who completed standard locoregional treatment, with minimal residual mKRAS disease (n = 25, 20 pancreatic cancer and 5 colorectal cancer), received monotherapy vaccination with lymph node-targeting ELI-002 2P, including mutant KRAS (mKRAS) amphiphile-peptide antigens (G12D, G12R) and amphiphile-adjuvant CpG-7909. At a median follow-up of 19.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
August 2025
AstraZeneca Farmacéutica Spain, Madrid, Spain.
Purpose: We aimed to evaluate adherence to oral antineoplastic therapy (OAT) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and its potential relationship with several clinical outcomes.
Methods: Observational, prospective, multicenter study performed by 6 hospital pharmacists in Spain. The primary outcome was the proportion of treatment adherence as evaluated by pill reconciliation during the 3-month active follow-up period.
AJNR Am J Neuroradiol
July 2025
From the Departments of Radiology (J.R.P), Neurology (A.J.L.) and Psychiatry (P.M.D., L.A.W), Duke University School of Medicine, Durham NC, USA; Duke-UNC Alzheimer's Disease Research Center (J.R.P, A.J.L., P.M.D.), Durham/Chapel Hill, NC, USA.
The advent of anti-amyloid therapies (AATs) for Alzheimer's disease (AD) has elevated the importance of MRI surveillance for amyloidrelated imaging abnormalities (ARIA) such as microhemorrhages and siderosis (ARIA-H) and edema (ARIA-E). We report a literature review and early quality assurance experience with an FDA-cleared assistive AI tool intended for detection of ARIA in MRI clinical workflows. The AI system improved sensitivity for detection of subtle ARIA-E and ARIA-H lesions but at the cost of a reduction in specificity.
View Article and Find Full Text PDF